Healthcare provider profile · identity verified

Sandy J Robertson, MD

Family Practice · NELLYSFORD, VA · NPI 1255339123

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	615	39
Pantoprazole Sodium	Pantoprazole Sodium	335	69
Amlodipine Besylate	Amlodipine Besylate	247	43
Rosuvastatin Calcium	Rosuvastatin Calcium	213	39
Atorvastatin Calcium	Atorvastatin Calcium	211	38
Montelukast Sodium	Montelukast Sodium	205	37
Carvedilol	Carvedilol	168	25
Levothyroxine Sodium	Levothyroxine Sodium	163	23
Metoprolol Succinate	Metoprolol Succinate	148	25
Sertraline Hcl	Sertraline Hcl	147	28
Torsemide	Torsemide	142	22
Lisinopril	Lisinopril	141	21
Eliquis	Apixaban	122	27
Furosemide	Furosemide	117	25
Losartan Potassium	Losartan Potassium	117	19
Buspirone Hcl	Buspirone Hcl	113	18
Allopurinol	Allopurinol	108	18
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	97	23
Duloxetine Hcl	Duloxetine Hcl	92	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	90	19
Potassium Chloride	Potassium Chloride	76	13
Spironolactone	Spironolactone	76	15
Tamsulosin Hcl	Tamsulosin Hcl	75	14
Metformin Hcl Er	Metformin Hcl	69	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	67	33
Trazodone Hcl	Trazodone Hcl	67	11
Pregabalin	Pregabalin	63	suppressed
Donepezil Hcl	Donepezil Hcl	59	13
Clopidogrel	Clopidogrel Bisulfate	54	12
Escitalopram Oxalate	Escitalopram Oxalate	54	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	53	suppressed
Risperidone	Risperidone	52	suppressed
Mirabegron Er	Mirabegron	44	suppressed
Mirtazapine	Mirtazapine	44	11
Glipizide	Glipizide	43	suppressed
Tramadol Hcl	Tramadol Hcl	42	14
Alendronate Sodium	Alendronate Sodium	41	suppressed
Dapagliflozin	Dapagliflozin Propanediol	41	suppressed
Memantine Hcl	Memantine Hcl	41	suppressed
Levetiracetam	Levetiracetam	40	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	39	14
Finasteride	Finasteride	39	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Benztropine Mesylate	Benztropine Mesylate	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Prednisone	Prednisone	35	19
Famotidine	Famotidine	34	12
Hydrochlorothiazide	Hydrochlorothiazide	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Methimazole	Methimazole	33	suppressed
Metformin Hcl	Metformin Hcl	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	21
Metoprolol Tartrate	Metoprolol Tartrate	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	17
Midodrine Hcl	Midodrine Hcl	29	suppressed
Aripiprazole	Aripiprazole	28	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Cephalexin	Cephalexin	28	suppressed
Latanoprost	Latanoprost	28	11
Lorazepam	Lorazepam	28	13
Risperidone Er	Risperidone Microspheres	28	suppressed
Calcitriol	Calcitriol	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Admelog	Insulin Lispro	26	12
Ezetimibe	Ezetimibe	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	22	15
Sucralfate	Sucralfate	21	suppressed
Letrozole	Letrozole	20	suppressed
Naltrexone Hcl	Naltrexone Hcl	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Cresemba	Isavuconazonium Sulfate	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	16
Divalproex Sodium Er	Divalproex Sodium	19	suppressed
Dexlansoprazole Dr	Dexlansoprazole	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	17	16
Atenolol	Atenolol	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	17	suppressed
Ketoconazole	Ketoconazole	17	11
Propranolol Hcl	Propranolol Hcl	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Insulin Lispro	Insulin Lispro	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Cefdinir	Cefdinir	15	11
Divalproex Sodium	Divalproex Sodium	15	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Ozempic	Semaglutide	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Risedronate Sodium	Risedronate Sodium	13	suppressed
Topiramate	Topiramate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Jardiance	Empagliflozin	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Omeprazole	Omeprazole	11	suppressed
Trueplus Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error